September 2026
The global lipid nanoparticles market size is evaluated at USD 1,301.42 million in 2026 and is expected to attain around USD 3,694.21 million by 2034, with a CAGR of 13.93%.
September 2026
The antihyperlipidemic market is valued at USD 15.02 billion in 2025 and is expected to expand at a CAGR of 5.64% during the forecast period. Research by Deepa Pandey, Senior Research Analyst.
September 2026
The global hyperlipidemia drugs market size is calculated at USD 24.80 billion in 2026 and is projected to surpass USD 35.24 billion by 2035 with a CAGR of 3.98%.
July 2026
The global lipid-lowering drugs market size was evaluated at USD 35.46 billion in 2025 and is projected to attain around USD 49.65 billion by 2035 with a CAGR of 3.42%.
November 2025
The global lecithin and phospholipids market size is estimated to hit around USD 11.92 billion by 2034 increasing from USD 7.20 billion in 2026, with a CAGR of 6.50%.
November 2025
The global pharmaceutical lipid-based excipients market size accounted for USD 2.02 billion in 2025 and is predicted to hit around USD 3.17 billion by 2034, growing at a CAGR of 5.13%.
July 2025
The global point of care lipid test market size was valued at USD 307.71 million in 2024 and is predicted to attain around USD 472.54 million by 2034 with a CAGR of 4.38%.
+1 650 460 3308
+61 485 981 310 +91 87933 22019
sales@precedenceresearch.com